TAISHO PHARMACEUTICAL INDONESIA TBK PT Instrumento Inactivo
Empresa Taisho Pharmaceutical Indonesia Tbk PT
Acciones
SQBB
ID1000070006
Farmacéuticos
|
Precio de cierre
Otros sitios de cotización
|
||
| - | - |
|
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Jun Kuroda
CEO | Chief Executive Officer | 68 | - |
David Pranadjaja
DFI | Director of Finance/CFO | - | - |
Budhy Herwindo
CTO | Chief Tech/Sci/R&D Officer | 44 | 01/01/17 |
Yukio Sawada
PRN | Corporate Officer/Principal | - | - |
| Comptroller/Controller/Auditor | - | - |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
Adji Baroto
BRD | Director/Board Member | 80 | 01/01/13 |
Takeshi Ishiguro
CHM | Chairman | 53 | 01/01/06 |
Osamu Murakami
BRD | Director/Board Member | 50 | 01/01/97 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 9 268 000 | 0 | 0 | - |
| Acción B | 0 | 972 000 | 0 | 0 |
Información de la empresa
PT Taisho Pharmaceutical Indonesia
Millenium Centennial Center Jalan Jenderal Sudirman Kavling 25
12920, Jakarta
+
http://www.taisho.co.id
Sector
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| +21,59 % | 44,15 mil M | |
| +23,03 % | 23,02 mil M | |
| +18,00 % | 15,33 mil M | |
| +12,26 % | 13,74 mil M | |
| +52,55 % | 12,16 mil M | |
| -10,02 % | 6839,19 M | |
| -0,05 % | 6787,61 M | |
| -8,87 % | 5725,52 M | |
| +13,88 % | 5658,74 M |
- Bolsa de valores
- Acciones
- Acción SQBB
- Empresa Taisho Pharmaceutical Indonesia Tbk PT
